Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
Publisher
Transactions of the Royal Society of Tropical Medicine and Hygiene(3)
Clinical Immunology(1)
Área temáticas
Enfermedades(4)
Farmacología y terapéutica(2)
Fisiología humana(2)
Medicina forense; incidencia de enfermedades(1)
Origen
scopus(4)
Comparison of two single-day regimens of triclabendazole for the treatment of human pulmonary paragonimiasis
ArticleAbstract: A well-tolerated single-day treatment regimen is required for the community-based treatment of pulmoPalabras claves:ECUADOR, Efficacy, Paragonimiasis, Paragonimus spp., TRICLABENDAZOLEAutores:Guderian R.H., Manuel H. Calvopina, Paredes W., Philip John CooperFuentes:scopusBartonellosis in Zamora Chinchipe province in Ecuador
ArticleAbstract: Human bartonellosis was investigated in the Ecuadorian province of Zamora Chinchipe; 17 cases were iPalabras claves:Bartonella bacilliformis, Bartonellosis, ECUADORAutores:Daniels R., Griffin G.E., Guderian R.H., Mauricio Espinel, Paredes W., Perera D., Philip John Cooper, Valdez M.Fuentes:scopusEotaxin and RANTES expression by the dermal endothelium is associated with eosinophil infiltration after ivermectin treatment of onchocerciasis
ArticleAbstract: The roles of eotaxin, RANTES, and MCP-3 expression in eosinophil recruitment to the site of parasitePalabras claves:Chemokines, Filarial, Helminth, Posttreatment reactionsAutores:Beck L., Deyampert N., Espinel I., Guderian R.H., Hartnell A., Jose P., Nutman T.B., Paredes W., Philip John CooperFuentes:scopusTreatment of human pulmonary paragonimiasis with triclabendazole: Clinical tolerance and drug efficacy
ArticleAbstract: An open clinical trial to determine the efficacy and tolerability of postprandial doses of triclabenPalabras claves:chemotherapy, ECUADOR, Efficacy, Paragonimiasis, Paragonimus mexicanus, tolerance, TRICLABENDAZOLEAutores:Guderian R.H., Manuel H. Calvopina, Martha E. Chico, Paredes W., Philip John CooperFuentes:scopus